Zymeworks — Deal History & Benchmarks
Total Deals
2
Across 1 therapeutic area
Total Deal Value
$580M
Cumulative transaction value
Most Active Year
2024
1 deal closed
Primary TA
Oncology
100% of deal activity
Market Analysis
Zymeworks has been involved in 2 transactions totaling $580M across Oncology. As a licensor (out-licensor), they have demonstrated a preference for licensing partnerships.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
How many deals has Zymeworks done?
Zymeworks has completed 2 verified transactions tracked in our database, spanning from 2020 to 2024. These deals have a combined value of $580M.
PRO
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.
or
Unlock Everything — $299/mo Pro7-day money-back guarantee · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.
Start Calculating